mode百度云100as
百度云100as 时间:2021-01-04 阅读:()
58HongKongMedJVol16No1#Supplement1#February2010Beta1subunit–dependentmodulationofBKchannelbymembranecholesterolWWu,CPLau,HFTse,GRLiDepartmentofMedicine,TheUniversityofHongKong,QueenMaryHospital,HongKongBackground:ThelargeconductanceCa2+-activatedK+(BKorMaxi-K)channelsareubiquitouslyexpressedindifferenttissueswithout(brain,liver,etc)orwith(smoothmuscleandheart)regulatorybeta-subunit,andplayanimportantroleinregulatingvariousphysiologicalprocessessuchascellexcitability,hormonesecretion,vascularactivity,etc.
RecentstudieshaveshownthatmembranecholesterolisamajorregulatorofseveralpotassiumchannelsincludingKirandKv1.
5channels.
However,theregulationofBKchannelsbycholesterolisnotfullyunderstood.
Methods:WholecellBKcurrentandBKsinglechannelcurrentwererecordedinwhole-cellpatchclampmodeandcell-attachedsinglechannelrecording,respectively,inHEK293cellsstablyexpressingMaxi-KgeneorMaxi-Kwithbeta1-subunit.
Results:Wefoundthatwhole-cellBKcurrentwassignificantlysuppressedwithcholesteroldepletionbymethyl-beta-cyclodextrin(MCD),whereascholesterol-saturated–MCDhadnoeffectonthecurrentamplitude.
SinglechannelrecordingshowedthatcholesteroldepletionsignificantlyreducedtheopenprobabilityofBKchannel,suggestingthatcholesteroldepletionlikelydecreasesthemembranechannelnumber.
Interestingly,incellsstablyexpressingSloandbeta1-subunit,depletionofmembranecholesterolincreasedBKcurrent,whilecholesterol-saturated–MCDreducedBKcurrent.
Conclusion:OurresultsdemonstratetheimportantevidencethatBKchannelsexhibitbeta1-subunit–dependentresponsestocholesterol.
TheenrichedcholesterolreducestheactivityofBKchannelsco-expressedwithMax-Kandbeta1-subunit,whichmayatleastinpartaccountsfortheoccurrenceofhypertensioninpatientswithhighplasmacholesterollevel,sincebeta-subunittranscriptsareabundantinvascularsmoothmuscle.
99PhaseI/IItrialofPTK787/ZK222584combinedwithintravenousdoxorubicinfortreatmentofpatientswithadvancedhepatocellularcarcinoma:implicationforanti-angiogenicapproachtohepatocellularcarcinomaTYau1,PChan1,KKNg2,STFan2,RTPoon21DepartmentofMedicine,TheUniversityofHongKong,QueenMaryHospital,HongKong2DepartmentofSurgery,TheUniversityofHongKong,QueenMaryHospital,HongKongBackground:ThisisaphaseI/IItrialaimingtoassesstheefficacyandtolerabilityofPTK787/ZK222584(PTK)incombinationwithintravenousdoxorubicinforthetreatmentofadvancedhepatocellularcarcinoma(HCC)patients.
Methods:InphaseI,advancedHCCpatientsreceivedPTKatescalatingdosestogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weekstoestablishthemaximumtolerateddose(MTD).
Subsequently,inphaseII,allpatientsreceivedthesameregimenwithoralPTKattheMTDdosetogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weeksforamaximumof6cycles.
Results:Ninepatientswererecruitedinphase1partwiththeMTDestablishedas750mgdaily.
Overall,27patientsreceivedtheregimenwithPTKat750mgdaily.
Themedianagewas52(range,23-73)yearsand63%ofpatientswerechronichepatitisBcarriers.
Notably,themajorityofpatientshadChildBcirrhosis.
Theoverallresponseratewas26.
0%withallpatientshavingpartialresponse,andanother20%ofpatientsachievedstablediseaseforatleast12weeks.
Themedianprogression-freesurvivalwas5.
4(0.
27-23.
6)monthsandoverallsurvivalwas7.
3(0.
8-23.
6)months.
Thecommonestgrade3or4non-haematologicaltoxicitiesweremucositis(11%)andalopecia(7%),respectively.
Grade3or4neutropeniawasobservedinseven(26%)patientswithtwohavingneutropenicsepsis.
Conclusion:ThecombinationofPTKwithintravenousdoxorubicinshowssynergisticactivityinadvancedHCCpatients.
Thus,theideaofcombininganti-angiogenicagenttogetherwithchemotherapymaywarrantfurtherevaluationinfutureclinicaltrialsofadvancedHCCpatients.
100
RecentstudieshaveshownthatmembranecholesterolisamajorregulatorofseveralpotassiumchannelsincludingKirandKv1.
5channels.
However,theregulationofBKchannelsbycholesterolisnotfullyunderstood.
Methods:WholecellBKcurrentandBKsinglechannelcurrentwererecordedinwhole-cellpatchclampmodeandcell-attachedsinglechannelrecording,respectively,inHEK293cellsstablyexpressingMaxi-KgeneorMaxi-Kwithbeta1-subunit.
Results:Wefoundthatwhole-cellBKcurrentwassignificantlysuppressedwithcholesteroldepletionbymethyl-beta-cyclodextrin(MCD),whereascholesterol-saturated–MCDhadnoeffectonthecurrentamplitude.
SinglechannelrecordingshowedthatcholesteroldepletionsignificantlyreducedtheopenprobabilityofBKchannel,suggestingthatcholesteroldepletionlikelydecreasesthemembranechannelnumber.
Interestingly,incellsstablyexpressingSloandbeta1-subunit,depletionofmembranecholesterolincreasedBKcurrent,whilecholesterol-saturated–MCDreducedBKcurrent.
Conclusion:OurresultsdemonstratetheimportantevidencethatBKchannelsexhibitbeta1-subunit–dependentresponsestocholesterol.
TheenrichedcholesterolreducestheactivityofBKchannelsco-expressedwithMax-Kandbeta1-subunit,whichmayatleastinpartaccountsfortheoccurrenceofhypertensioninpatientswithhighplasmacholesterollevel,sincebeta-subunittranscriptsareabundantinvascularsmoothmuscle.
99PhaseI/IItrialofPTK787/ZK222584combinedwithintravenousdoxorubicinfortreatmentofpatientswithadvancedhepatocellularcarcinoma:implicationforanti-angiogenicapproachtohepatocellularcarcinomaTYau1,PChan1,KKNg2,STFan2,RTPoon21DepartmentofMedicine,TheUniversityofHongKong,QueenMaryHospital,HongKong2DepartmentofSurgery,TheUniversityofHongKong,QueenMaryHospital,HongKongBackground:ThisisaphaseI/IItrialaimingtoassesstheefficacyandtolerabilityofPTK787/ZK222584(PTK)incombinationwithintravenousdoxorubicinforthetreatmentofadvancedhepatocellularcarcinoma(HCC)patients.
Methods:InphaseI,advancedHCCpatientsreceivedPTKatescalatingdosestogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weekstoestablishthemaximumtolerateddose(MTD).
Subsequently,inphaseII,allpatientsreceivedthesameregimenwithoralPTKattheMTDdosetogetherwithdoxorubicin60mg/m2givenasanintravenousbolusevery3weeksforamaximumof6cycles.
Results:Ninepatientswererecruitedinphase1partwiththeMTDestablishedas750mgdaily.
Overall,27patientsreceivedtheregimenwithPTKat750mgdaily.
Themedianagewas52(range,23-73)yearsand63%ofpatientswerechronichepatitisBcarriers.
Notably,themajorityofpatientshadChildBcirrhosis.
Theoverallresponseratewas26.
0%withallpatientshavingpartialresponse,andanother20%ofpatientsachievedstablediseaseforatleast12weeks.
Themedianprogression-freesurvivalwas5.
4(0.
27-23.
6)monthsandoverallsurvivalwas7.
3(0.
8-23.
6)months.
Thecommonestgrade3or4non-haematologicaltoxicitiesweremucositis(11%)andalopecia(7%),respectively.
Grade3or4neutropeniawasobservedinseven(26%)patientswithtwohavingneutropenicsepsis.
Conclusion:ThecombinationofPTKwithintravenousdoxorubicinshowssynergisticactivityinadvancedHCCpatients.
Thus,theideaofcombininganti-angiogenicagenttogetherwithchemotherapymaywarrantfurtherevaluationinfutureclinicaltrialsofadvancedHCCpatients.
100
ftlcloud9元/月，美国云服务器，1G内存/1核/20g硬盘/10M带宽不限/10G防御
ftlcloud(超云)目前正在搞暑假促销，美国圣何塞数据中心的云服务器低至9元/月，系统盘与数据盘分离，支持Windows和Linux，免费防御CC攻击，自带10Gbps的DDoS防御。FTL-超云服务器的主要特色：稳定、安全、弹性、高性能的云端计算服务，快速部署，并且可根据业务需要扩展计算能力，按需付费，节约成本，提高资源的有效利用率。活动地址：https://www.ftlcloud.com...
ZJI：520元/月香港服务器-2*E5-2630L/32GB/480G SSD/30M带宽/2IP
ZJI发布了一款7月份特别促销独立服务器：香港邦联四型，提供65折优惠码，限量30台(每用户限购1台)，优惠后每月520元起。ZJI是原来Wordpress圈知名主机商家：维翔主机，成立于2011年，2018年9月启用新域名ZJI，提供中国香港、台湾、日本、美国独立服务器(自营/数据中心直营)租用及VDS、虚拟主机空间、域名注册等业务。下面列出这款服务器的配置信息。香港邦联四型CPU：2*E5-2...
GreenCloudVPS$20/年多国机房可选，1核@Ryzen 3950x/1GB内存/30GB NVMe/10Gbps端口月流量2TB
GreencloudVPS此次在四个机房都上线10Gbps大带宽VPS，并且全部采用AMD处理器，其中美国芝加哥机房采用Ryzen 3950x处理器，新加坡、荷兰阿姆斯特丹、美国杰克逊维尔机房采用Ryzen 3960x处理器，全部都是RAID-1 NVMe硬盘、DDR4 2666Mhz内存，GreenCloudVPS本次促销的便宜VPS最低仅需20美元/年，支持支付宝、银联和paypal。Gree...
百度云100as为你推荐
-
海外主机为什么国外的主机和国内的有这么大的差别？台湾主机电脑主板那些牌子是台湾的?那些牌子是国产的?免费域名空间可绑域名的免费空间重庆虚拟空间现在重庆那家主机空间最好？网站空间商网站备案为什么是空间商备案？求解免费网站空间申请哪个网站可以申请免费的网页空间长沙虚拟主机长沙IDC，求长沙本地虚拟主机，大伙推荐推荐虚拟主机试用购买虚拟主机为什么商家会让你试用和测试？m3型虚拟主机建网站，M型虚拟主机和G型虚拟主机，选哪种好？www二级域名请问 www.aaa.bbb.com 是一级域名还是二级域名啊？能否备案？怎么备案？